Fernando Orden Rueda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernando Orden Rueda has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Anne U. Goeppert
Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK
1 shared publication- Benjamin Taylor
Discovery Biology UK, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
1 shared publication - David S. Rueda
Single Molecule Imaging Group, MRC-Laboratory of Medical Sciences, London, UK
1 shared publication Euan Gordon
Discovery Sciences IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
1 shared publicationFelix Kröner
Dynamic Biosensors GmbH, Lochhamer Strasse 15, 82152, Martinsried, Germany
1 shared publicationJon A. Read
Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 20 November 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-11
Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease
The CRISPR–Cas9 RNA-guided endonuclease system allows precise and efficient modification of complex genomes and is continuously developed to enhance specificity, alter targeting and add new functional moieties. However, one area yet to be explored is the base chemistry of the associated RNA molecules. Here we show the design and optimisation of hybrid DNA–RNA CRISPR and tracr molecules based on structure-guided approaches. Through careful mapping of the ribose requirements of Cas9, we develop hybrid versions possessing minimal RNA residues, which are sufficient to direct specific nuclease activity in vitro and in vivo with reduced off-target activity. We identify critical regions within these molecules that require ribose nucleotides and show a direct correlation between binding affinity/stability and cellular activity. This is the first demonstration of a non-RNA-guided Cas9 endonuclease and first step towards eliminating the ribose dependency of Cas9 to develop a XNA-programmable endonuclease.
- 20 November 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-11
Open AccessMapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease
The CRISPR–Cas9 RNA-guided endonuclease system allows precise and efficient modification of complex genomes and is continuously developed to enhance specificity, alter targeting and add new functional moieties. However, one area yet to be explored is the base chemistry of the associated RNA molecules. Here we show the design and optimisation of hybrid DNA–RNA CRISPR and tracr molecules based on structure-guided approaches. Through careful mapping of the ribose requirements of Cas9, we develop hybrid versions possessing minimal RNA residues, which are sufficient to direct specific nuclease activity in vitro and in vivo with reduced off-target activity. We identify critical regions within these molecules that require ribose nucleotides and show a direct correlation between binding affinity/stability and cellular activity. This is the first demonstration of a non-RNA-guided Cas9 endonuclease and first step towards eliminating the ribose dependency of Cas9 to develop a XNA-programmable endonuclease.